Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Sarcoma, Ewing × Radiation Dose Hypofractionation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Sarcoma 4 Pancreatic Neoplasms 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pituitary Neoplasms 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Nasopharyngeal Carcinoma 1 Meningioma 1 Lung Neoplasms 1 Limited Stage Small Cell Lung Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Carcinoma In Situ 1 Brain Neoplasms 1

Interventions

Temozolomide 6 cabozantinib 3 Vincristine 3 Cyclophosphamide 3 liposomal doxorubicin 2 irinotecan sucrosofate 2 fludarabine 2 Zoledronic Acid 2 Specimen Handling 2 Radiotherapy 2 PM 01183 2 Irinotecan 2 Drug Therapy 2 trilaciclib 1 talazoparib 1 silmitasertib 1 romiplostim 1 regorafenib 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 naxitamab 1 fluzoparib 1 fludarabine phosphate 1 X-Rays 1 Whole-Body Irradiation 1 Weight-Bearing 1 Triptorelin Pamoate 1 Topotecan 1 Tacrolimus 1 Surgical Procedures, Operative 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07188532 2026-01-23

BEAR

Mayo Clinic

Phase NA Recruiting

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡